Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Dettagli Bibliografici
Autore principale:	Tamanna, Mst. Taskia
Altri autori:	Sharmin, Dr. Sabrina
Natura:	Tesi
Lingua:	English
Pubblicazione:	Brac University 2023
Soggetti:	Senile plaques Alzheimer’s disease Apolipoprotein E Bridging integrator 1 Drug development Alzheimer's disease > Treatment > Congresses.
Accesso online:	http://hdl.handle.net/10361/18146

Documenti analoghi

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
di: Hassan, Md. Muhtaz
Pubblicazione: (2020)

Role of protein’s and future treatment options for Alzheimer’s Disease
di: Islam, Md. Irfath
Pubblicazione: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
di: Alim, Abdul
Pubblicazione: (2023)

Marine compounds in the treatment of Alzheimer’s disease
di: Parveen, Sanjana
Pubblicazione: (2022)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
di: Tabassum, Nadira
Pubblicazione: (2024)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
di: Chowdhury, Sariya Uzrat
Pubblicazione: (2022)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
di: Shehab, Habibul Mohsin
Pubblicazione: (2024)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
di: Aana, Afsara Sumon
Pubblicazione: (2021)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
di: Saha, Bithi Rani
Pubblicazione: (2023)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
di: Ishrat, Nowshin
Pubblicazione: (2024)

Alzheimer's disease and marriage : an intimate account /
di: Wright, Lore K.
Pubblicazione: (1993)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
di: Karmaker, Swastika
Pubblicazione: (2024)

A study on less explored plants with potential neuroprotective activity against neurodegenerative diseases
di: Nayeem, Abdullah Al
Pubblicazione: (2021)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
di: Tasneem, Sadia
Pubblicazione: (2021)

Emerging therapies of Alzheimer’s disease: a comprehensive review
di: Tasin, Md Abtahi
Pubblicazione: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
di: Aziz, Farhin
Pubblicazione: (2019)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
di: Afra, Sumaiya
Pubblicazione: (2022)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
di: Mostofa, Golam
Pubblicazione: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
di: Zaman, Rubaiyat
Pubblicazione: (2024)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
di: Halim, Rabea
Pubblicazione: (2022)

Exploring Alzheimer's disease prediction with XAI in various neural network models
di: Rahman, Quazi Ashikur, et al.
Pubblicazione: (2022)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
di: Mahee, Sadique Abdal
Pubblicazione: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
di: Haque, Mushfiqul
Pubblicazione: (2019)

An overview on Covid-19 and invention of its treatment by drugs
di: Nawer, Anika
Pubblicazione: (2022)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
di: Bakar, Osama Bin Abu
Pubblicazione: (2024)

An ambient assisted living system for Alzheimer’s patients
di: Abedin, Minhajul, et al.
Pubblicazione: (2023)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
di: Jahan, Nusrat
Pubblicazione: (2023)

A review on adult neurogenesis in Alzheimer’s disease
di: Akter, Moriam
Pubblicazione: (2022)

Detection of alzheimer's disease using deep learning
di: Hasan, Mahmudul, et al.
Pubblicazione: (2021)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
di: Roy, Aditya, et al.
Pubblicazione: (2023)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
di: Dey, Manashi
Pubblicazione: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
di: Sani, Mehedi Hasan, et al.
Pubblicazione: (2022)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
di: Alam, Badrul, et al.
Pubblicazione: (2016)

Role of circular RNA in neurological disease
di: Salsabil, Labiba
Pubblicazione: (2024)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
di: Mahbub, Riasat, et al.
Pubblicazione: (2022)

Skeleton /
di: Parkin, Peter

Drug repurposing in NCDs: benefits and challenges
di: Nasir, Naushin Sadia
Pubblicazione: (2021)

Multi-classification based Alzheimer's disease detection with comparative analysis from brain MRI scans using deep learning
di: Kabir, Azmain, et al.
Pubblicazione: (2022)

The development and designing of stent for treatment of Atherosclerosis
di: Munni, Monika Nasrin
Pubblicazione: (2021)

Early prediction of Alzheimer's disease using convolutional neural network
di: Abed, Mahjabeen Tamanna, et al.
Pubblicazione: (2020)